On the HCPLive Internal Medicine condition center page, resources on the topics of medical news and expert insight into internal medicine can be found. Content includes articles, interviews, videos, podcasts, and breaking news on internal medicine research, treatment, and drug development.
October 29th 2024
A study revealed using language models as diagnostic aids did not significantly enhance clinical reasoning or accuracy among physicians over conventional resources alone.
September 24th 2024
SimulatED™: Diagnosing and Treating Alzheimer’s Disease in the Modern Era
View More
Shaping the Management of COPD with Biologic Therapy
View More
Elevating Care for PAH: Applying Recommended Management Approaches to Maximize Outcomes
View More
Clinical Consultations™: Managing Depressive Episodes in Patients with Bipolar Disorder Type II
View More
Expert Illustrations & Commentaries™: Exploring the Role of Novel Agents for the Management of IgA Nephropathy
View More
Medical Crossfire®: Understanding the Advances in Bipolar Disease Treatment—A Comprehensive Look at Treatment Selection Strategies
View More
'REEL’ Time Patient Counseling: The Diagnostic and Treatment Journey for Patients With Bipolar Disorder Type II – From Primary to Specialty Care
View More
‘REEL’ Time Patient Counseling™: Navigating the Complex Journey of Diagnosing and Managing Fabry Disease
View More
Expert Illustrations & Commentaries™: Envisioning Novel Therapeutic Approaches to Managing ANCA-associated Vasculitis
View More
Clinical ShowCase™: Finding the Best Path Forward for Patients with COPD
View More
A Tethered Approach to Type 2 Diabetes Care – Connecting Insulin Regimens with Digital Technology
View More
Surv.AI Says™: What Clinicians and Patients Are Saying About Glucose Management in the Technology Age
View More
Clinical ShowCase™: Forming a Personalized Treatment Plan for a Patient With ANCA-Associated Vasculitis
View More
Addressing Healthcare Inequities: Tailoring Cancer Screening Plans to Address Inequities in Care
View More
Patient, Provider & Caregiver Connection™: Understanding the Patient Journey to Provide Personalized Care for Generalized Pustular Psoriasis
View More
Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice
View More
Clinical Consultations™: Addressing Elevated Phosphate Levels in Patients with END-STAGE Kidney Disease (ESKD)
View More
Patient, Provider & Caregiver Connection™: Implementing an Effective Management Plan to Improve Outcomes in IgA Nephropathy
View More
More on Catheter Ablation As First-line Therapy for Atrial Fibrillation
Study finds a lower rate of recurrent atrial tachyarrhythmias among patients with paroxysmal atrial fibrillation who underwent radiofrequency catheter ablation as a first-line treatment rather than taking antiarrhythmic drugs.
Low Vitamin D Levels in Pregnancy Linked to Increased Gestational Diabetes Risk
February 27th 2014New study results suggest low levels of vitamin during the first trimester are a modest yet consistent and independent risk factor for developing gestational diabetes and are associated with insulin resistance at the second trimester.
Alzheimer's Agitation Eased by Citalopram, But With Severe Adverse Effects
In a recent clinical trial, Celexa (citalopram) reduced agitation in patients with probable Alzheimer's disease (AD) compared to placebo, but the drug also produced severe cognitive and cardiac adverse events that prescribers must consider.
Pre-Op Intra-Aortic Balloon Pumps Improve Coronary Artery Bypass Grafting Results
February 25th 2014Though most studies on the preoperative use of intra-aortic balloon pumps in coronary artery bypass grafting patients have reported early results, they have not been able to determine long-term outcomes.
Ear Drops Beat Oral Medications in Children With Tympanostomy-Tube Otorrhea
A new study suggests antibiotic-glucocorticoid ear drops are superior to oral medications in children who suffer from acute otorrhea following the insertion of tympanostomy tubes for recurrent ear infections.
FDA Updates Warning Label for Hepatitis C Antiviral Drug
February 19th 2014The Food and Drug Administration has updated a drug warning label and medication guide for Victrelis (boceprevir) after receiving reports of abnormally low levels of red and white blood cells in patients who received it as part of combination treatment for hepatitis C.
FDA Panel Votes Against Naproxen's Cardiovascular Safety Claim
A US Food and Drug Administration (FDA) advisory panel has not found enough clinical evidence to conclude that naproxen presents a lower risk of cardiovascular (CV) thrombotic events than other nonsteroidal anti-inflammatory drugs (NSAIDs).
Late-Onset Alzheimer's Disease in Both Parents May Boost Dementia Risk in Adult Offspring
Patients who are free of dementia but have 2 parents with late-onset Alzheimer's disease may show signs of the disease in brain scans several years, if not decades, before they display clinical symptoms.
Evaluating Treatments for Painful Diabetic Neuropathy
February 13th 2014Meta-analysis of clinical trial data on the use of antidepressants and anticonvulsants for the treatment of painful diabetic neuropathy indicates gabapentin is the most efficacious agent for this condition, while the side effects associated with amitriptyline make it the least tolerable treatment option evaluated in the study.
Scientists Look at Role of DNA Variant and Novel Mechanism in Hepatitis C Virus
February 13th 2014Researchers wanting to untangle the genetic aspect of the hepatitis C virus that allows it to resist treatment discovered that one particular DNA variant acts like a powerful weapon that helps some people to better fight the disease.